MedTrace Logo

Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome

NCT03846817 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-07-28

No results posted yet for this study

Summary

This prospective study with a two-group comparison design investigates the effectiveness of 12-weeks of semi-structured and supervised physiotherapist-led treatment on self-reported hip and groin function in patients with femoroacetabular impingement syndrome with and without intra-articular hip pain. Determination of intra-articular hip pain is based on pain relief following an ultrasound-guided intra-articular anesthetic hip injection performed prior to commencing treatment.

Conditions

  • Femoroacetabular Impingement

Interventions

OTHER

Physiotherapist-led treatment

12-week of semi-standardized, progressive physiotherapist-led treatment aiming to increase hip muscle strength and load capacity.

Sponsors & Collaborators

  • La Trobe University

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Lasse Ishøi · Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

  • Per Hölmich · Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

  • Kristian Thorborg · Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

  • Joanne Kemp · La Trobe Sport and Exercise Medicine Research Centre, La Trobe University

  • Michael Reiman · Duke University Medical Center, Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-12
Primary Completion
2021-03-12
Completion
2021-03-12

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03846817 on ClinicalTrials.gov